Difficulty: Medium
Average Score: 82%
Practice
The MOST effective therapy for persistent allergic rhinitis is
Correct answer
D
Rationale
The correct answer is D) nasal budesonide spray for persistent allergic rhinitis.
Budesonide is a corticosteroid that helps reduce inflammation in the nasal passages, which is a key component of allergic rhinitis. By targeting the inflammation directly in the nasal passages, budesonide can effectively alleviate symptoms like nasal congestion, runny nose, sneezing, and itching.
Option A) oral desloratadine is a second-generation antihistamine that can help with symptoms like sneezing and itching, but it does not address the underlying inflammation in the nasal passages like budesonide does.
Option B) oral montelukast is a leukotriene receptor antagonist that is more commonly used for asthma and may not be as effective as corticosteroids for allergic rhinitis.
Option C) subcutaneous omalizumab is a biologic therapy reserved for severe allergic asthma and chronic idiopathic urticaria, not first-line treatment for allergic rhinitis.
In an educational context, it is important for pediatric clinical nurse specialists to understand the mechanisms of action of different medications for allergic rhinitis to provide evidence-based care to pediatric patients. Knowing when to use nasal corticosteroids like budesonide versus antihistamines or other therapies based on the severity and persistence of symptoms is crucial in managing pediatric patients with allergic rhinitis effectively.
Budesonide is a corticosteroid that helps reduce inflammation in the nasal passages, which is a key component of allergic rhinitis. By targeting the inflammation directly in the nasal passages, budesonide can effectively alleviate symptoms like nasal congestion, runny nose, sneezing, and itching.
Option A) oral desloratadine is a second-generation antihistamine that can help with symptoms like sneezing and itching, but it does not address the underlying inflammation in the nasal passages like budesonide does.
Option B) oral montelukast is a leukotriene receptor antagonist that is more commonly used for asthma and may not be as effective as corticosteroids for allergic rhinitis.
Option C) subcutaneous omalizumab is a biologic therapy reserved for severe allergic asthma and chronic idiopathic urticaria, not first-line treatment for allergic rhinitis.
In an educational context, it is important for pediatric clinical nurse specialists to understand the mechanisms of action of different medications for allergic rhinitis to provide evidence-based care to pediatric patients. Knowing when to use nasal corticosteroids like budesonide versus antihistamines or other therapies based on the severity and persistence of symptoms is crucial in managing pediatric patients with allergic rhinitis effectively.